Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation

Benicky, Julius, Sánchez-Lemus, Enrique, Honda, Masaru, Pang, Tao, Orecna, Martina, Wang, Juan, Leng, Yan, Chuang, De-Maw +1 more·2011·Neuropsychopharmacology

Cited by (254)

Items 201–254 of 254

  1. Anti-Inflammatory and Immune-Modulatory Therapeutic Approaches in Major Depression
    Norbert Müller · 2016 · Elsevier eBooks
  2. Mechanisms of angiotensin II to induce depression in diabetes
    Renata Vargas, Adriana B. Pedreáñez, Yenddy N. Carrero, Juan Pablo Hernández-Fonseca, Hugo Hernández–Fonseca, Jesús Mosquera-Sulbarán · 2025 · Diabetology International
  3. Candesartan Mitigates Perioperative Neurocognitive Disorders by Modulating Hypertension-Linked Neuroinflammatory Factor
    Zhenyu Wu, Yuqing Li, Taowu Gong, Jia Li, Pengcheng Zhao, Xufang Huo, Yuhang Zhu, Qingfan Zeng · 2025 · Neurochemical Research
  4. ACE1 does not influence cerebral Aβ degradation or amyloid plaque accumulation in 5XFAD mice
    Sohee Jeon, Alia O. Alia, Jelena Popovic, Robert J. Vassar, L. Cuddy · 2024 · bioRxiv
  5. Structure and function of neurovascular unit in arterial hypertension
    Ewa Koźniewska, Marta Aleksandrowicz · 2026 · Frontiers in Molecular Neuroscience
  6. Neurovascular Cognitive Alterations: Implication of Brain Renin–Angiotensin System
    Natalia Andrea Marchese, Brenda Solange Casarsa, Gustavo Baiardi, Claudia Bregonzio · 2015 · Springer eBooks
  7. Evaluation of anticonvulsant activity of angiotensin receptor antagonists in an animal model
    Asha Dattatraye Jadhav, Rakesh Ramratan Jadhav, Sudhir Laxmanrao Padwal, Swapnil S. Jadhav, Anand Kale, Prakashchandra Gade · 2020 · International Journal of Basic & Clinical Pharmacology
  8. Preliminary study of ovariectomy and chronic losartan-induced alterations in brain AT1 receptors
    Danial Mehranfard, Andrea Linares, Alesa Chabbra, Glenda Viggiano Campos, Aline M. A. de Souza, Hong Ji, Crystal Ann West, Kathryn L. Sandberg, Robert Charles Speth · 2021 · Brain Research
  9. Vascular Biology and Atherosclerosis of Cerebral Vessels
    Sophocles Chrissobolis, Christopher Graeme Sobey · 2015 · Elsevier eBooks
  10. Angiotensins and rheumatoid arthritis
    Natalya M. Savushkina, Elena Andreyevna Galushko, Natalia V. Demidova, Andrey V. Gordeev · 2019 · Rheumatology Science and Practice
  11. Modern Trends of Pharmacotherapy in PsychoNeuroImmunology
    Irina V. Sarvilina · 2024 · Integrated science
  12. Repurposed antihypertensive drugs for negative symptoms in schizophrenia: A systematic review and meta‐analysis
    Thiago Carnaval, My Bui, Jesús Villoria, Dolores Rodríguez Cumplido, José Manuel Menchón, Francisco Ciruela, Sebastián Videla · 2025 · Psychiatry and Clinical Neurosciences
  13. Discovery of Personalized Treatment for Immuno-Metabolic Depression—Focus on 11beta Hydroxysteroid Dehydrogenase Type 2 (11betaHSD2) and Toll-like Receptor 4 (TLR4) Inhibition with Enoxolone
    Harald Murck · 2025 · Pharmaceuticals
  14. The Candesartan Adjunctive Depression Trials—CADET
    Melanie M. Ashton, Chun Hui J. Park, Brisa S. Fernandes, Judy Hope, Chee H. Ng, Malcolm Hopwood, Jon‐Paul Khoo, Gin Singh Malhi, Stella May Gwini, John V. Amerena et al. · 2026 · Journal of Clinical Psychopharmacology
  15. Guideline-directed heart failure pharmacotherapy and depression/anxiety: a scoping review of heart failure and related cardiovascular populations
    Darshan Hullon, Danya Ansari, Abiya Ahad, Dyana Nasif, Ahmad Mustafa, Hamza Sohail Ansari, Akshay Singh Rekhraj · 2026 · European Journal of Clinical Pharmacology
  16. Differential involvement of hippocampal angiotensin 1 receptors in learning and memory processes in bulbectomized rats
    Roman E. Tashev, Margarita Ivanova, Stiliana P. Belcheva, Iren Belcheva · 2016 · Journal of Mind and Medical Sciences
  17. Unpuzzling the Comorbid Type 2 Diabetes and Hypertension-Related Cognitive Dysfunction and Stroke
    Inês Sebastião, Emanuel Candeias, Maria S. Santos, Catarina Resende Oliveira, Paula Isabel Moreira, Ana Isabel Duarte · 2017 · Springer series in translational stroke research
  18. Effect of AT1 receptor blockade on cardiovascular outcome after cardiac arrest: an experimental study in rats
    E. A. F. Araújo Filho, Maria José Carvalho Carmona, Denise Aya Otsuki, D. R. R. Maia, Luiz Guilherme Cernaglia Aureliano de Lima, Matheus Fachini Vane · 2023 · Scientific Reports
  19. Atherosclerosis and depression. Obvious and non-obvious relationships. Part I
    М. Д. Смирнова, Свирида Ольга Николаевна, Бланкова Зоя Николаевна, Fail T. Ageev · 2021 · Russian Cardiology Bulletin
  20. Receptors | Angiotensin Receptors
    Triveni R. Pardhi, Sadashiva S. Karnik · 2020 · Elsevier eBooks
  21. Renin-angiotensin System: A New Promising Therapeutic and Mechanisms for Depression and Anxiety
    Sizhu Gong, Fang Deng · 2022
  22. The central renin angiotensin II system – a genetic pathway, functional decoding and selective target engagement characterization in humans
    Ting Xu, Zhiyi Chen, Xinqi Zhou, Lan Wang, Feng Zhou, Dezhong Yao, Bo Zhou, Benjamin Becker · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Brain Disorder Approach from Neurotransmitters, Neuroinflammation, and RAS Imbalance Perspective
    María Josefina Piermarini, Sol Micaela Angulo, Victoria Belén Occhieppo, Claudia Bregonzio · 2024 · Springer eBooks
  24. Review Article Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease
    Edward C. Lauterbach · 2016
  25. Efeitos cardiovasculares causados pela microinjeção de angiotensina II no córtex pré-límbico de ratos
    Bruna Muza Nogari · 2015
  26. Treinamento aeróbio x disfunção autonômica na hipertensão espontânea: uma abordagem molecular em núcleos centrais de regulação.
    Gustavo Santos Masson · 2014 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  27. Pretreatment with low-dose fimasartan, one of angiotensin receptor blockers, inhibits NLRP3 inflammasome activation in a rat intracerebral hemorrhage model
    양슈리 · 2017
  28. Depression and Heart Failure in Male and Female Rats: Role of Inflammation and Estrogens
    Fatimah Najjar · 2019 · uO Research (University of Ottawa)
  29. A Vaccine for Ischemic Stroke
    Munehisa Shimamura, Tomohiro Kawano, Kouji Wakayama, Hironori Nakagami A · 2019 · Springer eBooks
  30. Cerebral Vascular Biology in Health and Disease
    T. Michael De Silva, Christopher Graeme Sobey · 2021 · Elsevier eBooks
  31. Olmesartan alleviates symptoms of chronic fatigue syndrome in mice
    Sadique Saqulain, Rahul Sharma, Ajay Singh Kushwah, Manish Kumar · 2022 · Research Square
  32. Neurobiological Principles: Psycho-Neuro-Immuno-Endocrinology
    Norbert Müller · 2022 · Springer eBooks
  33. Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I
    Sarah C. Hurt, Moin U. Vera, Steven Q. Le, Shih‐hsin Kan, Quang D. Bui, Patricia Dickson · 2023 · Molecular Genetics and Metabolism Reports
  34. WITHDRAWN: Azilsartan and Ceftriaxone, A Novel Combination Ameliorates Excitotoxicity Mediated Neuroinflammation in In-Vitro, and In-Vivo Models of Cerebral Ischemia
    Gaddam Narasimha Rao, Srikanth Jupudi, Devarakonda Krishna Prasad, Jeyaram Bharathi, Mohammad Zubair Baba, Antony Justin · 2024 · Research Square
  35. Neurovascular Barrier Protection in COVID‐19: Emerging Therapeutic Targets From SARS‐CoV‐2 Pathogenesis
    Qisen Chen, Kun Tan · 2025 · Journal of Medical Virology
  36. Angiotensin II regulates anxiety and social-affective top-down and bottom-up attention control in a sex-dependent manner
    Meng Han, Kun Fu, Wenyi Dong, Junjie Wang, Dan Liu, Qian Zhuang, Xiaolei Xu, Stefania Ferraro, Ting Xu, Keith Maurice Kendrick et al. · 2026 · Journal of Affective Disorders
  37. Additional file 6 of Discovery of therapeutic targets for spinal cord injury based on molecular mechanisms of axon regeneration after conditioning lesion
    Wang, Xiaoxiong, Wenxiang Li, Zhang, Jianping, Li, Jinze, Xianjin Zhang, Wang, Min, Wei, Zhijian, Feng, Shiqing · 2024 · Figshare
  38. Additional file 4 of Discovery of therapeutic targets for spinal cord injury based on molecular mechanisms of axon regeneration after conditioning lesion
    Wang, Xiaoxiong, Wenxiang Li, Zhang, Jianping, Li, Jinze, Zhang, Xianjin, Wang, Min, Wei, Zhijian, Feng, Shiqing · 2024 · Figshare
  39. Additional file 2 of Discovery of therapeutic targets for spinal cord injury based on molecular mechanisms of axon regeneration after conditioning lesion
    Wang, Xiaoxiong, Wenxiang Li, Zhang, Jianping, Li, Jinze, Xianjin Zhang, Wang, Min, Wei, Zhijian, Feng, Shiqing · 2024 · Figshare
  40. Additional file 5 of Discovery of therapeutic targets for spinal cord injury based on molecular mechanisms of axon regeneration after conditioning lesion
    Wang, Xiaoxiong, Wenxiang Li, Zhang, Jianping, Li, Jinze, Xianjin Zhang, Wang, Min, Wei, Zhijian, Feng, Shiqing · 2024 · Figshare
  41. Additional file 8 of Discovery of therapeutic targets for spinal cord injury based on molecular mechanisms of axon regeneration after conditioning lesion
    Wang, Xiaoxiong, Wenxiang Li, Zhang, Jianping, Li, Jinze, Xianjin Zhang, Wang, Min, Wei, Zhijian, Feng, Shiqing · 2024 · Figshare
  42. Additional file 3 of Discovery of therapeutic targets for spinal cord injury based on molecular mechanisms of axon regeneration after conditioning lesion
    Wang, Xiaoxiong, Wenxiang Li, Zhang, Jianping, Li, Jinze, Xianjin Zhang, Wang, Min, Wei, Zhijian, Feng, Shiqing · 2024 · Figshare
  43. Additional file 1 of Discovery of therapeutic targets for spinal cord injury based on molecular mechanisms of axon regeneration after conditioning lesion
    Wang, Xiaoxiong, Wenxiang Li, Zhang, Jianping, Li, Jinze, Xianjin Zhang, Wang, Min, Wei, Zhijian, Feng, Shiqing · 2024 · Figshare
  44. Additional file 7 of Discovery of therapeutic targets for spinal cord injury based on molecular mechanisms of axon regeneration after conditioning lesion
    Wang, Xiaoxiong, Wenxiang Li, Zhang, Jianping, Li, Jinze, Xianjin Zhang, Wang, Min, Wei, Zhijian, Feng, Shiqing · 2024 · Figshare
  45. Quantitative and morphological analyses reveal microglia-specific neuroinflammation in brain regions linked to cognitive function in ovariectomized and chronic intermittent hypoxia-exposed female rats
    Cephas B. Appiah, Kishor Kunwar, Rebecca Lynn Cunningham, J.Thomas Cunningham · 2026 · Brain Behavior & Immunity - Health
  46. WITHDRAWN: Azilsartan and Ceftriaxone, A Novel Combination Ameliorates Excitotoxicity Mediated Neuroinflammation in In-Vitro, and In-Vivo Models of Cerebral Ischemia
    Gaddam Narasimha Rao, Srikanth Jupudi, Devarakonda Krishna Prasad, Jeyaram Bharathi, Mohammad Zubair Baba, Antony Justin · 2026 · Research Square
  47. Vasopressin and angiotensin II pathways differentially modulate human fear response dynamics to looming threats
    Meng Han, Wenyi Dong, Kun Fu, Junjie Wang, Yuanhang Xu, Yueyuan Zheng, Keith Maurice Kendrick, Stefania Ferraro, Ting Xu, Dezhong Yao et al. · 2026 · PLoS Biology
  48. Newfangled Combination Azilsartan and Ceftriaxone Exhibited Potential Effects in In-Vitro and In-Vivo Models of Cerebral Ischemia: A Comprehensive Pharmacological Investigation
    Gaddam Narasimha Rao, Srikanth Jupudi, Krishna Prasad Devarakonda, Jeyaram Bharathi Jeyabalan, Nagaprabhu VN, Vivek Reddy Murthannagari · 2026 · Annals of Neurosciences
  49. Etude en imagerie biphotonique in vivo de l'impact de l'hypertension artérielle chronique sur la dynamique des cellules microgliales
    Elisa Grimoin · 2018 · theses.fr (ABES)
  50. Évaluation de l'impact de l'hypertension artérielle et de la réponse aiguë hypertensive à la phase aiguë de l'infarctus cérébral sur la réponse thrombo-inflammatoire
    Benjamin Maïer · 2023
  51. Neuroprotective effects of telmisartan in a harmaline-induced model of essential tremor: modulation of the renin-angiotensin system and inflammatory pathways
    Sama M. Farrag, Amr M. Emam, Ahmed Seif El Din Kamel, Muhammed A. Saad, Mona A. Kortam, Noha H. Sayed, Nevine Fathy Shamel Fathy · 2026 · Frontiers in Pharmacology
  52. Post-Traumatic Stress Disorder and Atherosclerosis: Co-Phenomena, or Cause-and-Effect?
    Mithil K. Penta, Saichandra Kalvakota, Robert T. Mallet · 2026 · Current Atherosclerosis Reports
  53. The role of renin-angiotensin system modulation in the pathophysiology of neuropsychiatric disorders
    Akhil Sharma, Tanya Goel, Ashi Mannan, Vetriselvan Subramaniyan, Thakur Gurjeet Singh · 2026 · Hormones and Behavior
  54. THE EFFECTS OF SUGAR INTAKE ON ENERGY CONTROL
    Changhui Zhao · 2015 · University Libraries (University of Maryland)